Tri-peptide hepatitis C serine protease inhibitors

Details Tri-peptide hepatitis C serine protease inhibitors Tri-peptide hepatitis C serine protease inhibitors

2007-09-25

2007-09-25

Tsang, Ceceilia J. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

10849107

ABSTRACT:
The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof:which inhibit serine protease activity, particularly the activity of hepatitis c virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis c virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

REFERENCES:
patent: 6329379 (2001-12-01), Llinas-Brunet et al.
patent: 6608027 (2003-08-01), Tsantrizos et al.
patent: 2002/0037998 (2002-03-01), Llinas-Brunet et al.
patent: 2003/0187018 (2003-10-01), Llinas-Brunet et al.
patent: 2004/0229818 (2004-11-01), Llinas-Brunet
patent: 2005/0049187 (2005-03-01), Brandenburg et al.
patent: WO-00/09543 (2000-02-01), None
patent: WO-00/59929 (2000-10-01), None
patent: WO-2003/053349 (2003-07-01), None
patent: WO-2004/072243 (2004-08-01), None
Ingallinella et al, Potent peptide inhibitors of humas hepatitis C virus NS3 protease are obtained by optimizing the cleavage products, Biochemistry (1998) vol. 37, 8906-8914.
March, “Advanced Organinc Chemistry,” 3rdEdition, p. 312.
Llinas-Brunet et al., Peptide-Based Inhibitors of the Hepatitis C Virus Serine Protease, Biorg. Med. Chem., Letters 8 (1998), 1713-1718.
A. Spatola, “Peptide Backbone Modifications: A Structure-Activity Analysis of Peptides Containing Amide Bond Surrogates, Conformational Constraints, and Rela,” Department of Chemistry, University of Louisville, Louisville Kentucky, pp. 267-357, XP 002032461.

Affiliated with

Also associated with

Rating

Tri-peptide hepatitis C serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tri-peptide hepatitis C serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tri-peptide hepatitis C serine protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3801181